- PTCT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $31.2 million.
- PTCT has traded 32,688 shares today.
- PTCT is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PTCT with the Ticky from Trade-Ideas. See the FREE profile for PTCT NOW at Trade-Ideas More details on PTCT: PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. Currently there are 5 analysts that rate PTC Therapeutics a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for PTC Therapeutics has been 435,200 shares per day over the past 30 days. PTC has a market cap of $1.6 billion and is part of the health care sector and drugs industry. Shares are up 199.8% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates PTC Therapeutics as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow.